Chairs: OD Messina and W Lems

Members: G Adami, N Binkley, B Buehring, J Carey, P Clark, F Cons Molina, G Kluwak, N Lane, J Morales Torres, G Mumbach, H Raterman, JJ Scali, M Vidal, L Zakraoui

To review the impact of inflammation and treatments on bone health and to produce recommendations on the role of different treatments, including biological agents.

• The COFOSAR project: A cohort study of osteoporotic fractures in patients with rheumatoid arthritis
• Fractures in patients with rheumatic diseases
• Bone and oral health 

1. Messina, O.D., Clark, P., Torres, J.M. et al. Vitamin D in inflammatory rheumatic diseases: still a challenge. Osteoporos Int (2026). https://doi.org/10.1007/s00198-026-08066-7
2. Raterman, H.G., Adami, G., Clark, P. et al. Osteoimmunology: Can We Prevent Bone Loss in Rheumatoid Arthritis with Modern Antirheumatic Drugs?. Calcif Tissue Int 117, 55 (2026). https://doi.org/10.1007/s00223-026-01504-y
3. Messina, O.D., et al., Chronic arthritides and bone structure: focus on rheumatoid arthritis—an update. Aging Clin Exp Res (2023). https://doi.org/10.1007/s40520-023-02432-9
4. Zerbini, C.A.F., Clark, P., Mendez-Sanchez, L. et al. Biologic therapies and bone loss in rheumatoid arthritis. Osteoporos Int 28, 429–446 (2017). https://doi.org/10.1007/s00198-016-3769-2